Kallikrein 3 and vitamin D receptor polymorphisms: potentials environmental risk factors for prostate cancer
© Hu et al.; licensee BioMed Central Ltd. 2014
Received: 20 August 2013
Accepted: 15 March 2014
Published: 22 April 2014
To investigate the relationship and interaction of the single nucleotide polymorphisms (SNPs) of KLK3 and VDR and environmental factors with the predisposition to prostate cancer within Chinese population.
The comparison between 108 patients and 242 healthy people was carried out by using the TaqMan/MGB Probe Technology to determine the genotypes of KLK3(rs2735839 is located between KLK2 and KLK3) and VDR (rs731236 is located exon 9). Univariate and multivariate logistic regression model were used to assess the connection of genetic polymorphisms and environmental risk factors with PCa by collecting demographic information, as well as BMI, consumption of cigarettes, alcohol, and tea, exercise, and other environmental risk factors.
The appearing frequencies of AA, AG, and GG genotypes at the SNPs rs2735839 (A/G) for KLK3 were 13.89%, 62.96% and 23.15% in PCa and 37.19%, 44.63%, 18.18% in control, respectively; these two groups are statistically different (P = 0.00). While the appearing frequencies of TT, TC, and CC genotypes at the SNPs rs731236 (T/C) for VDR were 88.89%, 9, 26%, 1.85% and 90.50%, 9.10%, 0.40% in control, respectively, with no significant statistical difference between the two group. The study confirmed decreasing risk in tea drinkers (OR = 0.58, 95% CI = 0.35-0.96).
Our studies indicate that environmental factor-tea drinking is associated with the development of PCa. The habit of drinking tea is a protective factor against PCa. The SNPs rs2735839 for KLK3 is strongly related to the development of PCa, while the SNPs rs731236 for VDR is not.
The virtual slide(s) for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/vs/9759981571058803.
KeywordsProstate cancer Nucleotide polymorphisms Environmental risk factor
The occurance of prostate cancer (PCa) in Europe and America is higher than other area. PCa is ranked the second most commonly occuring cancer among the male cancer patients in Europe and American, the major cause of male deaths in developed countries . With the aging of the population and the improvement of living conditions in recent years, PCa incidence among male Chinese has been increasing every year, China’s evarage standardized incidence rate was 1.6/10 million in 2002, while in Shanghai in 2000, the standardized incidence rate was 7.7 / 10 million. It is estimated that by 2010 in Shanghai, the incidence rate may be more than 10/100 000 . PCa is a common multifactorial, polygenic disease with significant heterogeneity. The mechanism of its inheritance and pathogenesis is very complex; Environmental factors and genetic factors jointly contribute to the occurrence of PCa. The studies by Sonoda et al  suggest that environmental factors such as diet and lifestyle, play an important role in the pathogenesis of PCa. Loci genome-wide association studies of multiple ethnic groups in recent years has identified some susceptibilities associated with PCa, however, the majority research was carried out among African and European ethnic groups [4–6], while related research on the Chinese population has been very limited.
The kallikrein 3 (Kallikrein 3, KLK3) gene is located on chromosome 19q13.33, which encodes prostate specific antigen (PSA) and is a serine protease kallikrein family member. Like other kallikrein, PCa kallikrein may be involved the occurrence of PCa and metastasis [7, 8]. The vitamin D receptor (Vitamin D Receptor, VDR) gene is located on chromosome 12q13.11, belonging to the steroid hormone receptor superfamily. About the mechanism of the VDR gene polymorphism and cancer relationship, it is now widely recognized that 1, 25 (OH) 2D3 and its analogs fix tumor cell growth cycle in the G1 phase via VDR, thereby inhibiting tumor cell proliferation. VDR gene polymorphism essentially unchanged the order of amino acids in VDR proteins, but affects the VDR protein expression at the transcriptional level. Change of the VDR gene polymorphism was considered to be associated with PCa predisposition  or progressive genotype , but different opinions are reported .
It has been confirm that the single nucleotide polymorphisms (SNPs) rs2735839 of KLK3 and the SNPs rs731236 of VDR are associated with PCa. Seldom research has been on the realationship of those two SNPs and PCa occurrence within the Chinese ethic group. This study is focused on the relationship between the KLK3 and VDR gene SNPs as well as environmental risk factors, and the occurance of PCa within the Chinese population.
Data and methods
Clinical studies of the 108 PCa patients were carried out from October 2007 to April 2010 at The First Affiliated People’s Hospital of Jiangsu University. These patients were confirmed to have PCa, with methods including B ultrasound, CT check and pathological diagnosis. The control group of 242 healthy people are from the community population without any history of PCa with normal serum PSA level.
Investigators developed a systematic questionnaire, and the survey was implemented via interiews of the patients. All the questionnaires were truthfully filled out with the consent of the respondents. Environmental risk factors, including body mass index (BMI), comsumption of alcohol, tea, and cigarettes, exercise, are evaluated. BMI factor is classified into two groups: BMI ≤ 24 kg/m2 and BMI > 24 kg/m2; regular alcohol consumption is defined as more than once every week and continued for at least 6 months. Tea consumption: seldom or never consumption (<4 times/week); regular tea comsumption (≥ 4 times/week); Smoking: non-smoker, moderate smoker (≤ 20 cigarettes/day), heavy smoker (> 20/day); exercise: seldom exercise (<4 times/week), regular exercise ( ≥ 4 times/week); each exercise needs to last for as least half an hour.
3 ml peripheral venous blood was extracted from each patient. After anti-coagulation by EDTA, peripheral blood genomic DNA was extracted using the extraction kit produced by Beijing TIANGEN, and stored at -20°C.
KLK3 and VDR genotype analysis
Primers and probes for genotyping of KLK3 and VDR SNPs
Both laboratory testing results and epidemiological data were entered into a computer, compared and checked to ensure the accuracy of the entry. Hardy-Weinberg (HWE) Genetic equilibrium analysis was carried out on the object of the study; SPSS16.0 statistical analysis was applied: χ2 test analysis of genotype frequencies, odds ratio (odds ratio, OR) and 95% CI estimate on the correlation strength of each studied factor with PCa; Logistic regression estimates on the relationship of the independent risk genotypes and the disease; multiplying and additive model analysis, which sums the interaction analysis using the relative excess risk due to interaction (RERI) and 95% CI assessment of environmental risk factors and genetic polymorphisms interaction. The test level (α) was 0.05.
The environmental risk factors
Environment factors of prostate cancer
Tea n (%)
Smoking n (%)
Sports n (%)
The analysis on the correlation of KLK3 and VDR genotype and PCa
Two genotype frequencies of prostate cancer between Pca and control group
OR (95% CI)
2.2.2 The correlation between clinico-pathological characteristics and the two SNPs. rs2735839 (KLK3 gene) and rs731236 (VDR gene) of wild-type and heterozygous/mutation distribution with age, Gleason score and PSA level is not associated with PCa.
Two SNPs and clinicopathological characteristics in prostate cancer
Multi-factor analysis and the interaction analysis results
Multivariate regression analysis of factors independently associated with prostate cancer
The interaction between the polymorphism of rs2735839 and environmental risk factors with PCa
OR 95% CI
Index RERI, 95% CI
So far, the etiology and pathogenesis of PCa is still elusive. Nevertheless, the continuous development of immunology and molecular biology methods provide the basis for the diagnosis and prognosis of prostate cancer [12, 13]. Lichtenstein et al  confirmed that 42% of the incidence of PCa can be attributed to genetic factors, and the rest is environment related. Studies on the relationship between the KLK3 and VDR polymorphisms as well as environmental factors and PCa occurance are very limited. Recent research on PCa whole-genome has revealed that several SNPs on chromosome 19q13.33 are related to the increased PCa risk . The most significantly associated SNP is rs2735839, located at the downstream 600 bp of the KLK3 gene and its encoding is KLK3, known as PSA. In an independent research on the group genome, including PCa, lung cancer, colon cancer, and ovarian cancer, Thomas et al.  found no PCa-susceptibility on chromosome 19. Our research has confirm that, patients with the SNP of the KLK3 gene, rs2735839, carrying the allele GG and AG, has a PCa risk 3.7 times higher than that carrying A homozygotes (OR = 3.78, 95% CI = 2.03 ~~ 7.07, P = 0.00). Xu et al.  reported that in terms of the chance of carrying dangerous allele G in rs2735839 SNPs, of localized PCa patients was significantly higher than of the advanced PCa patients (P = 0.03). Gleason score growth and the risk of gene frequencies confirmed no statistical significance, which is consistent with our finding. Zheng et al.  confirmed based on the research on the Chinese population, that the SNPs rs2723839 polymorphism of KLK3 related with the risk of PCa; Kader et al.  confirmed that the frequency of the rs2735839 gene and Gleason score are statistically significant. The difference in the conclusions may be due to genetic susceptibility and racial factors, as well as sufficiency of the sample size.
Lundin et al.  first reported that vitamin D (VD) may be associated with the causes of PCa. Cell culture experiments confirmed that VD inhibits PCa . Since VD produces physiological effects via its receptor (VDR), it is speculated that PCa susceptibility may depend on the polymorphism of the VDR genotype. The Taq I of several SNPs in VDR is located outside the 9th significant promoter region, which is SNPs rs731236. SNPs rs731236 and other flag material in this chromosomal region are stronly unbalanced; thus it is considered that this SNPs is strongly related to PCa occurance . Medeiros  confirmed that in the VDR Taq I genes, rs731236 polymorphism, people who carry allele C homozygotes only have 1/3 (OR = 0.34, 95% CI, 0.16 ~ 0.76, P <0.01) of the risk to have PCa compared with those who carry miscellaneous zygote or T homozygous, therefore CC homozygotes gene is thought to prevent individual from suffering from PCa. However Gsur et al.  confirmed that within the Caucasian population in Austria, the VDR Taq I gene polymorphism is not related to the risk of suffering from PCa; the frequencies of the CC genotype in PCa patients and the corresponding controls, are 18% and 12%, respectively, and difference is not statistically significant (OR = 1.76, 95% CI, 0.90 to 3.45, P = 0 07). Our study confirms that within the Chinese Han population, the appearing frequencies of the genotype TT, TC, and CC in the SNPs, rs731236 (T/C) VDR of PCa patients and the control group are 88.89%, 9.26%, 1.85% and 90.50%, 9.10%, 0.40%, (P = 0.643), and correlation is found between rs731236 and the occurrence PCa. Our research indicates that The rs731236 polymorphism may not be associated with PCa occurrence among the Chinese Han population, combined with the previous research, it suggest that gene polymorphism is different between different races.
Tumorigenesis is affected by both environmental and genetic factors. Univariate analysis of the environmental factors confirmed that alcohol consumption and tea consumpiton are related to prostate illness, where alcohol consumption increases the risk of suffering from PCa while tea drinking is a protective factor. Multivariate Logistic regression analysis confirmed that tea drinking reduces the PCa occurance. Epidemiological studies have pointed out that the lower occruance rate of PCa among Asian population compared with the Westerners may be realted to the larger conumption of tea by the former [25, 26]. The study has also found the correlation between the occurance of PCa and tea consumtion, which may be related to flavonols (protocatechuic) in green tea. Park  confirmed that protocatechuic can reduce PCa inplanted on mice. The analysis of environmental risk factors and genetic factors KLK3 gene polymorphisms (SNPs) rs2735839 revealed that multiplied interaction exists between tea consumption and rs2735839; Tea consumption may be against the dangerous gene GG + GA and protect people from PCa. Further in-depth research needs to be carry out in this aspect.
In summary, the results of this study suggest that the occurrence of PCa is related to the genotype of KLK3 SNPs rs2735839. The SNPs rs731236 genotype of VDR is not associated with PCa incidence. Environmental risk factors have impact on PCa occurance. Studies show that he expression of GOLPH3 and miR - 126 play a positive role in the malignant progression of PCa [28, 29]. The relationship between the genetic, environmental factors and PCa incidence still need further in-depth investigation with a largeer sample size in order to provide a scientific basis for PCa prevention and control.
- Parkin DM, Bray F, Ferlay J, Pisani P: Global cancer statistics, 2002. CA Cancer J Clin. 2005, 55: 74-108. 10.3322/canjclin.55.2.74.PubMedView ArticleGoogle Scholar
- Ye D, Li CL: Review and prospects of prostate cancer incidence trends. The Chinese Cancer. 2007, 17: 177-180.Google Scholar
- Sonoda T, Nagata Y, Mori M, Miyanaga N, Takashima N, Okumura K, Goto K, Naito S, Fujimoto K, Hirao Y: A case-control study of diet and prostate cancer in Japan: possible protective effect of traditional Japanese diet. Cancer Sci. 2004, 95 (3): 238-42. 10.1111/j.1349-7006.2004.tb02209.x.PubMedView ArticleGoogle Scholar
- Amundadottir LT, Sulem P, Gudmundsson J, Helgason A, Baker A, Agnarsson BA, Sigurdsson A, Benediktsdottir KR, Cazier JB, Sainz J: A common variant associated with prostate cancer in European and African populations. Nat Genet. 2006, 38: 652-658. 10.1038/ng1808.PubMedView ArticleGoogle Scholar
- Duggan D, Zheng SL, Knowlton M, Benitez D, Dimitrov L, Wiklund F, Robbins C, Isaacs SD, Cheng Y, Li G: Two genome-wide association studies of aggressive prostate cancer implicate putative prostate tumor suppressor gene DAB2IP. J Natl Cancer Inst. 2007, 99: 1836-44. 10.1093/jnci/djm250.PubMedView ArticleGoogle Scholar
- Chu LW, Reichardt JK, Hsing AW: Androgens and the molecular epidemiology of prostate cancer. Curr Opin Endocrinol Diabetes Obes. 2008, 15: 261-270. 10.1097/MED.0b013e3282febcf6.PubMedView ArticleGoogle Scholar
- Lawrence MG, Lai J, Clements JA: Kallikreins on steroids: structure, function, and hormonal regulation of prostate-specific antigen and the extended kallikrein locus. Endocr Rev. 2010, 31: 407-446. 10.1210/er.2009-0034.PubMedView ArticleGoogle Scholar
- Paliouras M, Borgono C, Diamandis EP: Human tissue kallikreins: the cancer biomarker family. Cancer Lett. 2007, 249: 61-79. 10.1016/j.canlet.2006.12.018.PubMedView ArticleGoogle Scholar
- Taylor JA, Hirvonen A, Watson M, Pittman G, Mohler JL, Bell DA: Association of prostate cancer with vitamin D receptor gene polymorphism. Cancer Res. 1996, 56: 4108-4110.PubMedGoogle Scholar
- Inglesb SA, Ross RK, Yu MC, Irvine RA, LaPera G, Haile RW, Coetzee GA: Association of prostate cancer risk with genetic polymorphisms in vitamin D receptor and androgen receptor. J Natl Cancer Inst (Bethesda). 1997, 89: 166-170. 10.1093/jnci/89.2.166.View ArticleGoogle Scholar
- Berndt SI, Dodson JL, Huang WY, Nicodemus KK: A systematic review of vitamin D receptor gene polymorphisms and prostate cancer risk. J Urol. 2006, 175: 1613-1623. 10.1016/S0022-5347(05)00958-4.PubMedView ArticleGoogle Scholar
- Dabir PD, Ottosen P, Høyer S, Hamilton-Dutoit S: Comparative analysis of three- and two-antibody cocktails to AMACR and basal cell markers for the immunohistochemical diagnosis of prostate carcinoma. Diagn Pathol. 2012, 7: 81-10.1186/1746-1596-7-81.PubMedPubMed CentralView ArticleGoogle Scholar
- Ishizaki F, Hara N, Koike H, Kawaguchi M, Tadokoro A, Takizawa I, Nishiyama T, Takahashi K, Hohenfellner R: Prediction of pathological and oncological outcomes based on extended prostate biopsy results in patients with prostate cancer receiving radical prostatectomy: a single institution study. Diagn Pathol. 2012, 7: 68-10.1186/1746-1596-7-68.PubMedPubMed CentralView ArticleGoogle Scholar
- Lichtenstein P, Holm NV, Verkasalo PK, Liadou A, Kaprio J, Koskenvuo M, Pukkala E, Skytthe A, Hemminki K: Environmental and heritable factors in the causation of cancer: analysis of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med. 2000, 343: 78-85. 10.1056/NEJM200007133430201.PubMedView ArticleGoogle Scholar
- Eeles RA, Kote-Jarai Z, Giles GG, Olama AA, Guy M, Jugurnauth SK, Mulholland S, Leongamornlert DA, Edwards SM, Morrison J: Multiple newly identified loci associated with prostate cancer susceptibility. Nat Genet. 2008, 40: 316-321. 10.1038/ng.90.PubMedView ArticleGoogle Scholar
- Thomas G, Jacobs KB, Yeager M, Kraft P, Wacholder S, Orr N, Yu K, Chatterjee N, Welch R, Hutchinson A: Multiple loci identified in a genome-wide association study of prostate cancer. Nat Genet. 2008, 40: 310-315. 10.1038/ng.91.PubMedView ArticleGoogle Scholar
- Xu JF, Isaacs SD, Sun JL, Li G, Wiley KE, Zhu Y, Hsu FC, Wiklund F, Turner AR, Adams TS: Association of prostate cancer risk variants with clinicopathologic characteristics of the disease. Clin Cancer Res. 2008, 14: 5819-5824. 10.1158/1078-0432.CCR-08-0934.PubMedPubMed CentralView ArticleGoogle Scholar
- Zheng SL, Hsing AW, Sun J, Sun J, Chu LW, Yu K, Li G, Gao ZR, Kim ST, Isaacs WB, Shen MC: Association of 17 prostate cancer susceptibility loci with prostate cancer risk in Chinese Men. Prostate. 2010, 70 (4): 425-432.PubMedPubMed CentralGoogle Scholar
- Kader AK, Sun JL, Isaacs SD, Wiley KE, Yan GF, Kim ST, Fedor H, DeMarzo AM, Epstein JI, Walsh PC: Individual and cumulative effect of prostate cancer risk-associated variants on clinicopathologic variables in 5,895 prostate cancer patients. Prostate. 2009, 69: 1195-1205. 10.1002/pros.20970.PubMedPubMed CentralView ArticleGoogle Scholar
- Lundin AC, Soderkvist P, Eriksson B, Bergman-Jungeström M, Wingren S: Association of breast cancer progression with a vitamin D receptor gene polymorphism, South—East Sweden Breast Cancer Group. Cancer Res. 1999, 59 (10): 2332-2334.PubMedGoogle Scholar
- Ye WZ, Reis AF, Velho G: Identification of a novel Tru9 I polymorphism in the human vitamin D receptor gene. J Hum Genet. 2000, 45 (1): 56-57. 10.1007/s100380050011.PubMedView ArticleGoogle Scholar
- Alagarasu K, Selvaraj P, Swaminathan S, Narendran G: Narayanan PR.5′ regulatory and 3′ untranslated region polymorphisms of vitamin D receptor gene in south Indian HIV and HIV-TB patients. J Clin Immunol. 2009, 29: 196-204. 10.1007/s10875-008-9234-z.PubMedView ArticleGoogle Scholar
- Medeiros R, Morais A, Vasconcelos A, Costa S, Pinto D, Oliveira J, Lopes C: The role of vitamin D receptor gene polymorphisms in the susceptibility to prostate cancer of a southern European popularion. J Hum Genet. 2002, 47: 413-418. 10.1007/s100380200060.PubMedView ArticleGoogle Scholar
- Gsur A, Madersbacher S, Haidinger G, Schatzl G, Marberger M, Vutuc C, Micksche M: Vitamin D receptor gene polymorphism and prostate cancer risk. Prostate. 2002, 5l: 30-34.View ArticleGoogle Scholar
- Saleem M, Adhami VM, Siddiqui IA, Asim M, Mukhtar H: Tea beverage in chemoprevention of prostate cancer: a mini-review. Nutr Cancer. 2003, 47: 13-23. 10.1207/s15327914nc4701_2.PubMedView ArticleGoogle Scholar
- Kurahashi N, Sasazuki S, Iwasaki M, Inoue M, Tsugane S, JPHC Study Group: Green tea consumption and prostate cancer risk in Japanese men: a prospective study. Am J Epidemiol. 2008, 167: 71-77.PubMedView ArticleGoogle Scholar
- Park OJ, Surh YJ: Chemopreventive potential of epigallocatechin gallate and genistein: evidence from epidemiological and laboratory studies. Toxicol Lett. 2004, 150: 43-56. 10.1016/j.toxlet.2003.06.001.PubMedView ArticleGoogle Scholar
- Sun X, Liu Z, Yang Z, Xiao L, Wang F, He Y, Su P, Wang J, Jing B: Association of Micro- RNA-126 expression with clinicopathological features and the risk of bio chemical recurrence in prostate cancer patients undergoing radical prostatectomy. Diagn Pathol. 2013, 8: 208-10.1186/1746-1596-8-208.PubMedPubMed CentralView ArticleGoogle Scholar
- Hua X, Yu L, Pan W, Huang X, Liao Z, Xian Q, Fang L, Shen H: Increased expression of Golgi phosphoprotein-3 is associated with tumor aggressiveness and poor prognosis of prostate cancer. Diagn Pathol. 2012, 7: 127-10.1186/1746-1596-7-127.PubMedPubMed CentralView ArticleGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited.